Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 6 51-6, 2005, Pages

  Pace, Thaddeus W W ^a,b   Spencer, Robert L ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glucocorticoid negative feedback; Hypothalamic pituitary adrenal axis regulation; RU28318

Indexed keywords

CORTICOSTEROID RECEPTOR; CORTICOSTERONE; MINERALOCORTICOID RECEPTOR; OXPRENOATE POTASSIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DISEASE SEVERITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; RECEPTOR OCCUPANCY;

ADRENALECTOMY; ANIMALS; CORTICOSTERONE; HANDLING (PSYCHOLOGY); HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RESTRAINT, PHYSICAL; SPIRONOLACTONE; STRESS;

EID: 19444365671     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00521.2004     Document Type: Article

References (31)

1. Arriza JL, Simerly RB, Swanson LW, and Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1: 887-900, 1988.
2. Arvat E, Barbara M, Giordano R, Pellegrino M, Broglio F, Gianotti L, Maccario M, Camanni F, and Ghigo E. Mineralocorticoid receptor blockade by canrenoate increases both the spontaneous and stimulated adrenal functions in humans. J Clin Endocrinol Metab 86: 3176-3181, 2001.
3. Bradbury MJ, Akana SF, and Dallman MF. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology 134: 1286-1296, 1994.
4. Chou YC and Luttge WG. Activated type II receptors in brain cannot rebind glucocorticoids: relationship to progesterone's antiglucocorticoid actions. Brain Res 440: 67-68, 1988.
5. Cole MA, Kaiman BA, Pace TWW, Topczewski F, Lowrey MJ, and Spencer RL. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation. J Neuroendocrinol 12: 1034-1042, 2000.
6. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, and Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 43: 113-173, 1987.
7. De Kloet ER, Vreugdenhil E, Oitzl MS, and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19: 269-301, 1998.
8. Dodt C, Werner K, Fehm HL, and Born J. Antimineralocorticoid canrenoate enhances secretory activity of the hypothalamic-pituitary-adrenocortical (HPA) axis in humans. Neuroendocrinlogy 58: 570-574, 1993.
9. Francis AB, Rubin BA, Pace TWW, Ginsberg AB, and Spencer RL. ICV injection of RU28362 differentially activates brain glucocorticoid receptors and does not suppress restraint stress-induced corticosterone production. [online]http://sfn.scholarone.com/itin2003/index.html
10. Herman JP. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell Mol Neurobiol 13: 349-372, 1993.
11. Heuser I, Deuschle M, Weber B, Stalla GK, and Holsboer F. Increased activity of the hypothamus-pituitary-adrenal system after treatment with the mineralocortioid receptor antagonist spironolactone. Psychoneuroendocrinology 25: 513-518, 2000.
12. Kaiman BA and Spencer RL. Rapid corticosteroid-dependent regulation of mineralocorticoid receptor protein expression in rat brain. Endocrinology 143: 4184-4195, 2002.
13. Keller-Wood ME and Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 5: 1-24, 1984.
14. Kim PJ, Cole MA, Kalman BA, and Spencer RL. Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies. J Steroid Biochem Mol Biol 67: 213-222, 1998.
15. Kovacs KJ, Foldes A, and Sawchenko PE. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J Neurosci 20: 3843-3852, 2000.
16. Litwack G. The glucocorticoid receptor at the protein level. Cancer Res 48: 2636-2640, 1988.
17. Mattsson C, Lai M, Noble J, McKinney E, Yau JL, Seckl JR, and Walker BR. Obese Zucker rats have reduced mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hippocampus- implications for dysregulation of the hypothalamic-pituitary-adrenal axis in obesity. Endocrinology 144: 2997-3003, 2003.
18. Oitzl MS, van Haarst AD, Sutanto W, and de Kloet ER. Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 20: 655-675, 1995.
19. Patchev VK, Brady LS, Karl M, and Chrousos GP. Regulation of HSP90 and corticosteroid receptor mRNA by corticosterone levels in vivo. Mol Cell Endocrinol 103: 57-64, 1994.
20. Plotsky PM. Pathways to secretion of andrenocorticotrophin: a view from the portal. J Neuroendocrinol 3: 1-9, 1991.
21. Ratka A, Sutanto W, Bloemers M, and de Kloet ER. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50: 117-123, 1989.
22. Reul JMHM and de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511, 1985.
23. Sanchez MM, Young LJ, Plotsky PM, and Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 20: 4657-4668, 2000.
24. Spencer RL, Kalman BA, Cotter CS, and Deak T. Discrimination between changes in glucocorticoid receptor expression and activation in rat brain using western blot analysis. Brain Res 868: 275-286, 2000.
25. Spencer RL, Kim PJ, Kaiman BA, and Cole MA. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 139: 2718-2726, 1998.
26. Spencer RL, Miller AH, Moday H, Stein M, and McEwen BS. Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. Endocrinology 133: 1941-1950, 1993.
27. Spencer RL, Young EA, Choo PH, and McEwen BS. Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res 514: 37-48, 1990.
28. Tacker MM, Leach CS, Owen CA, and Rummer JA. Levels of cortisol, corticosterone, cortisone and 11-deoxycortisol in the plasma of stressed and unstressed subjects. J Endocrinol 76: 165-166, 1978.
29. Van Haarst A, Oitzl M, and de Kloet ER. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem Res 22: 1323-1328, 1997.
30. Weidenfeld J and Feldman S. Glucocorticoid feedback regulation of adrenocortical responses to neural stimuli: role of CRF-41 and corticosteroid type I and type II receptors. Neuroendocrinology 58: 49-56, 1993.
31. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, and Akil H. The role of mineralocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation in humans. J Clin Endocrinol Metab 83: 3339-3345, 1998.